An interventional study of MCI and Sham MCI in Stroke and Stroke, Acute, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-04-08.
Sponsored by Northwestern University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Stroke by Northwestern University — 6 open to participants now, 8 under way, none of them phase 3. Stroke · Northwestern University.
Among the 24 studies in Stroke by Northwestern University, this one is the 2nd largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2018, is one of 17 with no phase, and was the 10th registered.
8,269 studies on the registry are indexed under Stroke; 2,062 are open to participants now.
Browse Stroke studies →6 of the 24 studies in Stroke by Northwestern University are open now, in 1 country. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 18–85
Northwestern University · Sites in United States
Ages 18–80 · Healthy volunteers
Northwestern University · Sites in United States
Ages 18+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 21–100
Northwestern University · Sites in United States
Ages 18–80
By country, each count listing its studies:
Of the 1,419 Stroke studies recruiting now, 695 (49%) set no upper age limit and 283 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 21 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 96 is above the median of 48 across 6,037 interventional studies indexed under Stroke.
Median enrollment 52 across the 20 interventional studies, 104 across the 4 observational. Of the 15 that completed or were terminated, 5 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
2 of the studies in Stroke by Northwestern University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04312269Northwestern UniversityCombining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke | 2027-01-30 |
| NCT03401762Northwestern UniversityWearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 24 studies in Stroke by Northwestern University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to explore the feasibility of using a wearable device, called a myoelectric-computer interface (MCI), to improve arm movement in people who have had a stroke.
Impaired arm movement after stroke is caused not just by weakness, but also by impaired coordination between joints due to abnormal co-activation of muscles. These abnormal co-activation patterns are thought to be due to abnormal movement planning.The MCI aims to reduce abnormal co-activation by providing feedback about individual muscle activations.
This randomized, controlled, blinded study will test the home use of an MCI in chronic and acute stroke survivors.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Chronic stroke participants
Acute stroke participants
Exclusion Criteria:
Decoupling 2 muscles at a time with MCI
Behavioral: MCI
Decoupling 3 muscles at a time with MCI
Behavioral: MCI
Decoupling muscles with MCI while reaching to targets
Behavioral: MCI
Sham control group
Behavioral: Sham MCI
Decoupling muscles with MCI in acute stroke subjects
Behavioral: MCI
Acute stroke subjects sham comparator
Behavioral: Sham MCI
EMG-controlled game
Sham control game
Wolf Motor Function Test
Timed
Time frame: baseline to 6 weeks
Fugl-Meyer Assessment - Upper Extremity (UE)
Time frame: baseline to 6 weeks
Motor Activity Log
Time frame: baseline to 6 weeks
Modified Ashworth Scale
Total score
Time frame: baseline to 6 weeks
Fugl-Meyer Assessment UE
Time frame: baseline to 10 weeks
Wolf Motor Function Test
Timed
Time frame: baseline to 10 weeks
Started Jan 2018 (actual). Primary completion is estimated for Apr 2027, 111 months after the start.
Of 3,119 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 111 months is above that.
Counting every sponsor, half of 3,263 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.